Orla Mining (ORLA) stock edges higher as gold rebounds; Fed minutes in focus
30 December 2025
1 min read

Orla Mining (ORLA) stock edges higher as gold rebounds; Fed minutes in focus

NEW YORK, December 30, 2025, 12:51 ET — Regular session

Shares of Orla Mining Ltd (ORLA) rose about 0.7% to $13.80 in midday trading on Tuesday on the NYSE American. The stock touched $14.23 and $13.71 so far in the session.

The move mirrored a rebound across precious-metals miners after bullion swung violently at the start of the week. For gold producers, sharp day-to-day moves matter because revenue is priced off the metal while many operating costs do not reset as quickly.

Markets also have a macro catalyst later Tuesday, when the Federal Reserve publishes minutes from its December policy meeting. Shifts in rate-cut expectations can move real yields and the dollar — two of gold’s main inputs.

Spot gold was up 0.9% at $4,369.59 an ounce at 11:29 a.m. ET, after suffering its biggest daily percentage loss since Oct. 21 on Monday. “Things have stabilised somewhat today, the trade remains generally favourable,” said Peter Grant, vice president and senior metals strategist at Zaner Metals. 1

Monday’s selloff followed a decision by futures exchange operator CME Group to raise margin requirements on precious-metals contracts, according to Investopedia. Higher margins mean traders must post more cash to hold positions, which can force faster liquidations when prices swing. 2

In Canada, the S&P/TSX Composite index was up 0.2% by mid-morning and the TSX gold sub-index added 1.3% as precious metal prices bounced back. Market participants pointed to year-end portfolio rebalancing in thin trade. 3

Orla says it runs two operating gold mines — Camino Rojo in Mexico and the Musselwhite mine in Ontario — and is advancing the South Railroad project in Nevada. Camino Rojo uses heap leaching, a process that extracts metal from crushed ore using a chemical solution. 4

That mix leaves Orla’s shares highly sensitive to bullion and to sentiment on mid-tier miners. When gold volatility rises, equities often move more than the commodity because earnings forecasts swing on the metal price.

Investors also have a company-specific calendar ahead: Orla’s first quarterly dividend of $0.015 per share has a record date of Jan. 12 and is slated to be paid on Feb. 10, the company’s dividend policy page shows. The board can adjust future payouts based on cash flow, capital needs and other factors. 5

On the growth side, Orla has said it expects an optimized feasibility study for the South Railroad Project early in the first quarter of 2026, with final construction permits expected in the second quarter. It expects construction to start mid-2026 and first production in 2028. 6

Stock Market Today

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

7 February 2026
New York, Feb 7, 2026, 09:33 (ET) — Market closed. MARA Holdings, Inc. shares ended Friday up 22.3% at $8.24, with about 82.4 million shares traded. Bitcoin was last around $68,928 on Saturday. The weekend pause matters because miners like MARA have become a fast, sometimes messy read-through on risk appetite. “The market looks like it was getting a bit overdone to the downside,” said Robert Pavlik, a senior portfolio manager at Dakota Wealth, pointing to technical buying after a rough stretch for tech and other risk assets. 1 That sensitivity cuts both ways. A Reuters report this week said
Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

7 February 2026
Apple shares closed up 0.8% at $278.12 Friday, then slipped 0.3% after hours. A global DRAM shortage is raising component costs, putting pressure on Apple’s pricing ahead of its Feb. 24 shareholder meeting. CEO Tim Cook said memory prices will rise “sharply” but gave no details on possible iPhone price hikes. Investors await signals before next week’s U.S. inflation data.
Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

7 February 2026
Roivant shares surged 22.4% to $25.82 after Phase 2 data showed its drug brepocitinib outperformed placebo in cutaneous sarcoidosis, with no serious adverse events. The company plans a Phase 3 trial in 2026 and has filed for FDA approval in dermatomyositis. Quarterly revenue reached $2 million, with a $313.7 million loss. Cash holdings stood at $4.5 billion.
Gold Fields stock rebounds as gold steadies, with Fed minutes next
Previous Story

Gold Fields stock rebounds as gold steadies, with Fed minutes next

Pan American Silver stock today: PAAS climbs as silver rebounds after margin shakeout
Next Story

Pan American Silver stock today: PAAS climbs as silver rebounds after margin shakeout

Go toTop